An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics".

@article{Dove2015AnAT,
  title={An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics".},
  author={E. Dove and I. {\"O}. Barlas and Kean Birch and C. Boehme and Alexander Borda-Rodriguez and W. Byne and F. Chaverneff and Y. Çoşkun and Marja‐Liisa Dahl and T. Dereli and Shyam Diwakar and L. Elbeyli and L. Endrenyi and Belgin Eroğlu-Kesim and L. Ferguson and Kıvanç G{\"u}ng{\"o}r and U. G{\"u}rsoy and N. Hekim and Farah Huzair and K. Kaushik and I. Kickbusch and O. Kıroğlu and E. Kolker and E. K{\"o}n{\"o}nen and B. Lin and A. Llerena and Faruk Malhan and B. Nair and G. Patrinos and Ş. Sardaş and {\"O}. Sert and S. Srivastava and L. Steuten and Cengiz Toraman and E. Vayena and Wei Wang and L. Warnich and Vural {\"O}zdemir},
  journal={Omics : a journal of integrative biology},
  year={2015},
  volume={19 8},
  pages={
          435-42
        }
}
  • E. Dove, I. Ö. Barlas, +35 authors Vural Özdemir
  • Published 2015
  • Political Science, Medicine
  • Omics : a journal of integrative biology
  • Diagnostics spanning a wide range of new biotechnologies, including proteomics, metabolomics, and nanotechnology, are emerging as companion tests to innovative medicines. In this Opinion, we present the rationale for promulgating an "Essential Diagnostics List." Additionally, we explain the ways in which adopting a vision for "Health in All Policies" could link essential diagnostics with robust and timely societal outcomes such as sustainable development, human rights, gender parity, and… CONTINUE READING
    12 Citations
    Roadmap for Establishing Large-Scale Genomic Medicine Initiatives in Low- and Middle-Income Countries.
    EPMA-World Congress 2015
    • 5
    • PDF
    The availability and affordability of orphan drugs for rare diseases in China
    • 17

    References

    SHOWING 1-10 OF 56 REFERENCES
    Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action
    • 26
    • PDF
    Aligning incentives to fulfil the promise of personalised medicine
    • 65
    Getting human rights right in global health policy
    • 8
    A Delphi Technology Foresight Study: Mapping Social Construction of Scientific Evidence on Metagenomics Tests for Water Safety
    • 12
    • PDF
    Health in all policies: where to from here?
    • 34
    • PDF
    Health in all policies--from what to how.
    • P. Puska
    • Medicine
    • European journal of public health
    • 2014
    • 83
    • PDF
    NTDs V.2.0: “Blue Marble Health”—Neglected Tropical Disease Control and Elimination in a Shifting Health Policy Landscape
    • P. Hotez
    • Medicine
    • PLoS neglected tropical diseases
    • 2013
    • 86
    • PDF
    Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation.
    • 10
    • PDF
    Genomic sovereignty and the African promise: mining the African genome for the benefit of Africa
    • 47
    • PDF
    Personalizing medicine: futures present and past.
    • R. Tutton
    • Medicine
    • Social science & medicine
    • 2012
    • 90